💨 Abstract

Neurogene Inc. (NGNE) reported a Q1 loss of $22.6 million, or $1.08 per share, falling short of Wall Street's expected loss of $1.05 per share, as estimated by five analysts surveyed by Zacks Investment Research. The figures were announced by the New York-based company on Friday, May 9, 2025.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖